The mechanism of anti-tumor effects involves inhibition of telomerase activity and cell cycle arrest in the G0/G1 phase, down-regulation of nuclear factor kappa-B and cyclin D1 and enhanced NK cell-mediated cytotoxicity [18, 37, 39]. The gene discussed is CCND1; the disease is neoplasm.